Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
出版年份 2023 全文链接
标题
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-26
DOI
10.1038/s41571-023-00825-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exploring a new pathway for biomarker-based approval of immunotherapies
- (2023) Josep M. Llovet Nature Reviews Clinical Oncology
- Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma
- (2023) Takeshi Yokoo et al. RADIOLOGY
- AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
- (2023) Amit G. Singal et al. HEPATOLOGY
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
- (2023) Kiyoshi Hasegawa et al. HEPATOLOGY RESEARCH
- Aetiology of liver disease and response to immune checkpoint inhibitors: An updated meta-analysis confirms benefit in those with non-viral liver disease
- (2023) Tim Meyer et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
- (2023) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
- (2023) Frederico Costa et al. Cancer Medicine
- Breakthroughs in Hepatocellular Carcinoma Therapies
- (2023) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Financial Burden of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- (2023) Manasa Narasimman et al. Clinical Gastroenterology and Hepatology
- Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
- (2023) Magdalena Espinoza et al. Gastroenterology
- International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance
- (2023) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
- (2023) Shukui Qin et al. LANCET
- Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
- (2023) Shukui Qin et al. JAMA Oncology
- Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma
- (2023) Sarah Cappuyns et al. JAMA Oncology
- Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
- (2022) Nicolas Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
- (2022) Ian Lockart et al. HEPATOLOGY
- Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992‐2018
- (2022) Christian S. Alvarez et al. HEPATOLOGY
- Declining disease burden of HCC in the U nited S tates, 1992–2017: A population‐based analysis
- (2022) Jianglong Han et al. HEPATOLOGY
- Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication
- (2022) Peter P. Mueller et al. JOURNAL OF HEPATOLOGY
- HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Systematic Review and Meta-Analysis
- (2022) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era
- (2022) Atsushi Hiraoka et al. ONCOLOGY
- Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019
- (2022) Yuan Liu et al. Cancer Medicine
- Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
- (2022) Ze-Hong Huang et al. BMC CANCER
- Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
- (2022) Maedeh Amini et al. BMC PUBLIC HEALTH
- Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
- (2022) Mohammad A. Karim et al. Clinical Gastroenterology and Hepatology
- Risk factors for HCC in contemporary cohorts of patients with cirrhosis
- (2022) Fasiha Kanwal et al. HEPATOLOGY
- Aspirin Use and the Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
- (2022) Freddie Bray et al. LANCET ONCOLOGY
- Changing epidemiology of hepatocellular carcinoma in Asia
- (2022) Chen‐hao Zhang et al. LIVER INTERNATIONAL
- A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
- (2022) Daniel Q. Huang et al. Cell Metabolism
- Hepatocellular Carcinoma Incidence in Alcohol-associated Cirrhosis: Systematic Review and Meta-analysis
- (2022) Daniel Q. Huang et al. Clinical Gastroenterology and Hepatology
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
- (2022) Andrew M. Brown et al. Cancer Medicine
- Hepatocellular Carcinoma in Africa: Challenges and Opportunities
- (2022) Mohamed El-Kassas et al. Frontiers in Medicine
- Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
- (2022) Neehar D. Parikh et al. JAMA Network Open
- Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
- (2022) Shen Zhang et al. World Journal of Gastrointestinal Surgery
- LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
- (2022) R.S. Finn et al. ANNALS OF ONCOLOGY
- Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
- (2022) Laura Torrens et al. CLINICAL CANCER RESEARCH
- Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
- (2022) Darren Jun Hao Tan et al. HEPATOLOGY
- Global burden of primary liver cancer in 2020 and predictions to 2040
- (2022) Harriet Rumgay et al. JOURNAL OF HEPATOLOGY
- Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
- (2022) Neehar D. Parikh et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma Chemoprevention with Generic Agents
- (2022) Fahmida Rasha et al. SEMINARS IN LIVER DISEASE
- Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality
- (2022) Hyun-seok Kim et al. JAMA Network Open
- Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma
- (2022) Fabrizio Di Benedetto et al. JAMA Surgery
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters
- (2021) Sean A. Woolen et al. Clinical Gastroenterology and Hepatology
- International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
- (2021) Amit G. Singal et al. GASTROENTEROLOGY
- Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
- (2021) Pankaj Gupta et al. JOURNAL OF HEPATOLOGY
- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
- (2021) Vinod K. Rustgi et al. GASTROENTEROLOGY
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Etiologies and outcomes of cirrhosis in a large contemporary cohort
- (2021) Hannes Hagström et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
- (2021) Karim J. Halazun et al. JAMA Surgery
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- (2021) E.A. Klein et al. ANNALS OF ONCOLOGY
- Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
- (2021) Naga P. Chalasani et al. Clinical Gastroenterology and Hepatology
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium
- (2021) Neil Mehta et al. GASTROENTEROLOGY
- IMbrave150: Exploratory analysis to examine the association between treatment response and overall survival (OS) in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor).
- (2021) Michel Ducreux et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
- (2021) Naomi F. Lange et al. JOURNAL OF HEPATOLOGY
- Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States
- (2021) Hyun-seok Kim et al. JOURNAL OF HEPATOLOGY
- Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging
- (2021) Dong Hwan Kim et al. Cancers
- Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations
- (2021) David T. Fetzer et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
- (2021) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance
- (2021) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Global, regional and national burden of primary liver cancer by subtype
- (2021) Harriet Rumgay et al. EUROPEAN JOURNAL OF CANCER
- Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
- (2021) Nicole E. Rich et al. HEPATOLOGY
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients
- (2021) Hyo Jung Park et al. LIVER INTERNATIONAL
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Current epidemiology in hepatocellular carcinoma
- (2021) Peter Konyn et al. Expert Review of Gastroenterology & Hepatology
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi‐center cohort of patients with cirrhosis
- (2020) Nicole E. Rich et al. HEPATOLOGY
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center
- (2020) Lydia Giannitrapani et al. Biomed Research International
- Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2020) Neehar D Parikh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018
- (2020) Donghee Kim et al. GASTROENTEROLOGY
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Utilization of hepatocellular carcinoma surveillance in patients with cirrhosis: A systematic review and meta‐analysis
- (2020) Erin Wolf et al. HEPATOLOGY
- Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
- (2020) Cheng‐Hao Tseng et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
- (2020) Masatoshi Kudo et al. Liver Cancer
- Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma
- (2020) Nicole E. Rich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cost-Effectiveness of Hepatocellular Carcinoma Surveillance
- (2020) Neehar D. Parikh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Patient-Reported Barriers are Associated with Receipt of Hepatocellular Carcinoma Surveillance in a Multi-Center Cohort of Patients with Cirrhosis
- (2020) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis
- (2020) Peter Jepsen et al. JOURNAL OF HEPATOLOGY
- Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
- (2020) Xiaojun Ge et al. BMJ Open
- A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development
- (2020) Jeong Hee Yoon et al. Liver Cancer
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Racial and Ethnic Disparities in Survival Among Patients with Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
- (2020) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
- (2020) John D. Gordan et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- The National Institute on Minority Health and Health Disparities Research Framework
- (2019) Jennifer Alvidrez et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients
- (2019) Emma Nilsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
- (2019) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Unexpected Rapid Increase in the Burden of Nonalcoholic Fatty Liver Disease in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
- (2019) Feng Zhou et al. HEPATOLOGY
- Adiponectin accounts for gender differences in hepatocellular carcinoma incidence
- (2019) Elisa Manieri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
- (2019) George N. Ioannou et al. GASTROENTEROLOGY
- Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
- (2019) Mark Yarchoan et al. CANCER RESEARCH
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
- (2019) Jian Lu et al. Lancet Gastroenterology & Hepatology
- Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
- (2019) Zhijiang Miao et al. JOURNAL OF INFECTIOUS DISEASES
- TCT-472 Distribution of Coronary Flow Capacity Is Different Among the Groups by Abnormal CFR/HMR in Nonobstructive Coronary Artery Disease Patients
- (2019) Jin-Sin Koh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma
- (2019) Yong Xia et al. JAMA Oncology
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Global timing of hepatitis C virus elimination in high‐income countries
- (2019) Homie Razavi et al. LIVER INTERNATIONAL
- Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
- (2018) Jessica L. Petrick et al. BRITISH JOURNAL OF CANCER
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
- (2018) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
- (2018) Delphine Maucort-Boulch et al. INTERNATIONAL JOURNAL OF CANCER
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study
- (2018) Mindie H Nguyen et al. JOURNAL OF INFECTIOUS DISEASES
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance
- (2018) Okeefe L. Simmons et al. Clinical Gastroenterology and Hepatology
- Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients with Cirrhosis: A Randomized Clinical Trial
- (2018) Amit G. Singal et al. HEPATOLOGY
- Cost-effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With HCV Infection and Advanced Fibrosis
- (2018) Hooman Farhang Zangneh et al. Clinical Gastroenterology and Hepatology
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Coffee and the risk of hepatocellular carcinoma and chronic liver disease
- (2017) Francesca Bravi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
- (2017) Alvin W. T. Ng et al. Science Translational Medicine
- Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- (2017) Nicolas Goossens et al. Clinical and Translational Gastroenterology
- MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
- (2017) So Yeon Kim et al. JAMA Oncology
- Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
- (2016) Sarah Berhane et al. Clinical Gastroenterology and Hepatology
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
- (2016) Omair Atiq et al. HEPATOLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Length time bias in surveillance for hepatocellular carcinoma and how to avoid it
- (2016) Alessandro Cucchetti et al. HEPATOLOGY RESEARCH
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
- (2016) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
- (2016) Elena Raffetti et al. LIVER INTERNATIONAL
- Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
- (2016) Luis A. García Rodríguez et al. PLoS One
- The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition
- (2015) Krasimira Aleksandrova et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B
- (2015) Ju Dong Yang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
- (2015) Amit G. Singal et al. AMERICAN JOURNAL OF MEDICINE
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Changing epidemiology of hepatocellular carcinoma in Asia
- (2015) George Boon-Bee Goh et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Improved Surveillance for Hepatocellular Carcinoma With a Primary Care–Oriented Clinical Reminder
- (2015) Lauren A. Beste et al. Clinical Gastroenterology and Hepatology
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- (2015) Anna S.F. Lok et al. HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion
- (2015) Jian-Hong Zhong et al. MEDICINE
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
- (2015) Bruno Vincenzi et al. PLoS One
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Screening for Hepatocellular Carcinoma in Chronic Liver Disease
- (2014) Devan Kansagara et al. ANNALS OF INTERNAL MEDICINE
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- Molecular targets of aspirin and cancer prevention
- (2014) L Alfonso et al. BRITISH JOURNAL OF CANCER
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Statin use and risk of liver cancer: an update meta-analysis
- (2014) M. Shi et al. BMJ Open
- Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial
- (2014) Chunfeng Qu et al. PLOS MEDICINE
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
- (2013) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
- (2013) A M Attallah et al. BRITISH JOURNAL OF CANCER
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Resection of Hepatocellular Carcinoma Without Cirrhosis
- (2012) Brian Shrager et al. ANNALS OF SURGERY
- Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
- (2012) Yan Liu et al. EUROPEAN JOURNAL OF CANCER
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
- (2012) Sasan Roayaie et al. HEPATOLOGY
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
- (2012) Kai Feng et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
- (2011) J. S.-W. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
- (2011) Emily Jane Gallagher et al. Annals of the New York Academy of Sciences
- The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
- (2011) Katherine A. McGlynn et al. Clinics in Liver Disease
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
- (2011) Jean-Claude Trinchet et al. HEPATOLOGY
- Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males
- (2011) Donna L. White et al. HEPATOLOGY
- Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?
- (2011) Hossein Poustchi et al. HEPATOLOGY
- Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study
- (2011) D. Trichopoulos et al. JNCI-Journal of the National Cancer Institute
- Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
- (2010) W. Alazawi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
- (2010) Valentina Santi et al. JOURNAL OF HEPATOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
- (2009) Mei-Hwei Chang et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started